Buscar
12/05/2026
Influence of Decreased Kidney Function on Plasma Biomarkers of Neurodegenerative Disorders in Routine Care: Confirmation of the Interest of Ratios
Mondésert, E, Cristol, JP, Bargnoux, AS, Duchiron, M, Busto, GU, Hirtz, C, Barnier-Figue, G, Perrein, F, Turpinat, C, Jurici, S, Gabelle, A, Bennys, K, Lehmann, S, Delaby, C. Influence of Decreased Kidney Function on Plasma Biomarkers of Neurodegenerative Disorders in Routine Care: Confirmation of the Interest of Ratios. NEUROLOGY. 2026; 106(9)DOI:10.1212/WNL.0000000000214931. PMID:41980230. IF:8.500(Q1/1D).
12/05/2026
Contribution of hospitals and clinical services to global warming: a scoping systematic review
Merino-Urrutia, W, Cárcamo-Fuentes, C, Peña, M, Zalej-Rakela, B, Rodríguez-García, J, Gottschalk-Cuevas, MD, Rubilar-Rocha, F, Martínez-Zapata, MJ. Contribution of hospitals and clinical services to global warming: a scoping systematic review. Frontiers in Public Health. 2026; 14DOI:10.3389/fpubh.2026.1778269. PMID:42205444. IF:3.400(Q1/2D).
07/05/2026
The role of Spanish clinical pharmacologists in economic evaluations of health technologies
Delgado-Espinoza, CE, Antonijoan, RM, Martínez-Zapata, MJ. The role of Spanish clinical pharmacologists in economic evaluations of health technologies. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2026; 82(6)DOI:10.1007/s00228-026-04070-2. PMID:42091708. IF:2.700(Q2/5D).
07/05/2026
Novel treatment strategies in cardiogenic shock: an update on ongoing clinical trials
Padilla-Lopez, M, Manicone, F, Holle, SLD, Wenzl, FA, Kimmoun, A, Mebazaa, A, Sionis, A. Novel treatment strategies in cardiogenic shock: an update on ongoing clinical trials. HEART FAILURE REVIEWS. 2026; 31(1)DOI:10.1007/s10741-026-10637-z. PMID:42095992. IF:4.200(Q1/3D).
04/05/2026
Pharmacogenomics of anti-seizure medications in epilepsy: a systematic review of genetic predictors of response and tolerance
Barguilla, A, Riera, P, Ros-Castelló, V, Muino, E, Sierra-Marcos, A. Pharmacogenomics of anti-seizure medications in epilepsy: a systematic review of genetic predictors of response and tolerance. Expert Review of Neurotherapeutics. 2026; 26(5)DOI:10.1080/14737175.2026.2647028. PMID:41875007. IF:3.400(Q2/3D).
04/05/2026
ARIAN protocol: a phase III study of sacituzumab and zimberelimab for the treatment of patients with non-small cell lung cancer
Provencio, M, Aguiar, D, Antoñanzas, M, Areses, MC, Azkárate, A, Barba, A, Bernabé, R, Blanco, R, Borregón, M, Campos, B, Coves, J, de Castro, J, Domènech, M, Dómine, M, Campelo, RG, Lucía-Gozálvez, C, Lázaro-Quintela, M, Insa, A, Juan-Vidal, O, Castro, RL, Martínez-Marti, A, Medina, S, Moreno, MA, Nadal, E, Olivares-Hernández, A, Reguart, N, Sala, MA, Medina, K, Vila, L, Massutí, B. ARIAN protocol: a phase III study of sacituzumab and zimberelimab for the treatment of patients with non-small cell lung cancer. EXPERT OPINION ON BIOLOGICAL THERAPY. 2026; 26(5)DOI:10.1080/14712598.2026.2677905. PMID:42159280. IF:4.000(Q2/3D).
04/05/2026
Phenotypic clustering of newly diagnosed type 2 diabetes in a Mediterranean cohort
Fernandez-Camins, B, Vlacho, B, Rojo-López, MI, Granado-Casas, M, Gratacòs, M, Ortega-Bravo, M, Cendros-Massioui, M, Palmieri, F, Perera-LLuna, A, Franch-Nadal, J, Mauricio, D. Phenotypic clustering of newly diagnosed type 2 diabetes in a Mediterranean cohort. Cardiovascular Diabetology. 2026; 25(1)DOI:10.1186/s12933-026-03198-w. PMID:42083025. IF:10.600(Q1/1D).
03/05/2026
Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer
Cella, L, Finocchiaro, A, Slusarczyk, A, Krajewski, W, Velasco, JC, Subiela, JD, Claps, F, Grobet-Jeandin, E, Del Giudice, F, Gallioli, A, Laukhtina, E, Marcq, G, Mari, A, Afferi, L, Albisinni, S, Soria, F, Hurle, R, Paciotti, M, Ferro, M, Perdonà, S, Mertens, LS, Moschini, M, Pradere, B, Contieri, R. Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer. Future Oncology. 2026; 22(11)DOI:10.1080/14796694.2026.2661768. PMID:42041162. IF:2.600(Q3/6D).
02/05/2026
Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium
Baldi, GG, Giani, C, Ljevar, S, Denu, RA, Napolitano, A, Han, I, Brunello, A, Bhadri, V, Sebio, A, Andelkovic, V, Campos, F, Scanferla, R, Abreu, MH, Desar, IME, Ogura, K, Wong, DD, Bae, S, Bakhshi, S, Lefler, DS, Marquina, G, Mazzocca, A, Nakazawa, MS, Thway, K, Kim, HS, Chiusole, B, Connolly, EA, Terés, R, Antonescu, C, Bellan, E, Bovee, JVMG, Davis, JL, Tos, APD, Di Blasi, E, Lazar, AJ, Sbaraglia, M, Schaefer, IM, Taverna, S, Gronchi, A, Miceli, R, Chen, TW, Stacchiotti, S. Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium. EUROPEAN JOURNAL OF CANCER. 2026; 238DOI:10.1016/j.ejca.2026.116666. PMID:41819027. IF:7.100(Q1/2D).
01/05/2026
Biosynthetic Prosthesis Omniflow II in Chronic-Limb Threatening Ischemia: Results of the Multicenter National Registry Omni-Femoropopliteal
Baturone, A, Serrano, FJ, Camblor, LA, Alonso, M, García, F, Rodríguez, M, Marquina, R, Egaña, JM, Lozano, C, Landaluce, M, Garzón, N, Miralles, M, Fité, J, Escudero, JR, Olmos, D, Gomez-Palonés, F, Ligero, JM, Martín, A. Biosynthetic Prosthesis Omniflow II in Chronic-Limb Threatening Ischemia: Results of the Multicenter National Registry Omni-Femoropopliteal. ANNALS OF VASCULAR SURGERY. 2026; 126DOI:10.1016/j.avsg.2025.12.037. PMID:41544849. IF:1.600(Q2/5D).
01/05/2026
European Stroke Organisation (ESO), European Association of Neurosurgical Societies (EANS) and European Society for Minimally Invasive Neurological Therapy (ESMINT) guideline on aneurysmal subarachnoid haemorrhage
Vergouwen, MDI, Ramos-Pachon, A, Terecoasa, EO, Willett, N, Cuadrado-Godia, E, Gaberel, T, Gizewski, ER, Helbok, R, Ho, LA, Hugelshofer, M, Korja, M, Meling, TR, Psychogios, MN, Rinkel, GJE, Taschner, CA, Vajkoczy, P, Etminan, N. European Stroke Organisation (ESO), European Association of Neurosurgical Societies (EANS) and European Society for Minimally Invasive Neurological Therapy (ESMINT) guideline on aneurysmal subarachnoid haemorrhage. European Stroke Journal. 2026; 11(5)DOI:10.1093/esj/aakag043. PMID:42095754. IF:4.500(Q1/2D).
01/05/2026
KDEL-mediated modulation of intracellular trafficking in cell-targeted protein drugs
Volta-Durán, E, Alba-Castellon, L, Arena, LA, Sánchez, JM, Casanova, I, Mangues, R, Villaverde, A, Vázquez, E, Unzueta, U. KDEL-mediated modulation of intracellular trafficking in cell-targeted protein drugs. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2026; 222DOI:10.1016/j.ejpb.2026.115020. PMID:41690333. IF:4.300(Q1/2D).
01/05/2026
Assessing the Value Contribution of Vyvgart® (Efgartigimod Alfa) in the Treatment of Generalized Myasthenia Gravis with Acetylcholine Receptor Antibody in Spain Through Multi-criteria Decision Analysis (Jan, 10.1007/s12325-026-03490-x, 2026)
Cortés-Vicente, E, Guerrero, A, Díaz, C, Martínez, E, Toja-Camba, FJ, Abad, MR, Serra, JM, Trillo, JL, Machín, CM, Gil, A. Assessing the Value Contribution of Vyvgart® (Efgartigimod Alfa) in the Treatment of Generalized Myasthenia Gravis with Acetylcholine Receptor Antibody in Spain Through Multi-criteria Decision Analysis (Jan, 10.1007/s12325-026-03490-x, 2026). ADVANCES IN THERAPY. 2026; 43(5)DOI:10.1007/s12325-026-03532-4. PMID:41817916. IF:4.000(Q1/3D).
01/05/2026
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial
Behrens, GMN, Assoumou, L, Liegeon, G, Antinori, A, Micán, R, Genderini, FG, Post, FA, Rockstroh, JK, Hamzah, L, Domingo, P, Curran, A, Laguno, M, Fletcher, C, Moody, J, Pozniak, A. Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial. LANCET INFECTIOUS DISEASES. 2026; 26(5)DOI:10.1016/S1473-3099(25)00681-4. PMID:41344354. IF:31.000(Q1/1D).
01/05/2026
Sotorasib in Advanced KRAS G12C-Mutated NSCLC Results From the Global Expanded Access Program Including Patients With Poor Performance Status and a History of CNS Metastases
Novello, S, Rabinovich, NM, Shih, JY, Pelizzari, G, Stevenson, J, Majem, M, Ferreira, CG, Petty, WJ, Arriola, E, Castagneris, N, De Castro, J, Morbeck, I, Bauman, J, Toschi, L, Zer, A, Metro, G, Kalmadi, S, Martinez, AA, Al Husaini, H, Meloni, AR, Nduka, C, Ardito-Abraham, C, Xia, CH, Awad, MM. Sotorasib in Advanced KRAS G12C-Mutated NSCLC Results From the Global Expanded Access Program Including Patients With Poor Performance Status and a History of CNS Metastases. Jto Clinical And Research Reports. 2026; 7(5)DOI:10.1016/j.jtocrr.2026.100974. PMID:42006282. IF:(Q/D).
01/05/2026
Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801
Espinosa, E, Berciano-Guerrero, MA, Muñoz-Couselo, E, Puértolas, T, Manzano, JL, Soria, A, De Miguel, PA, Crespo, G, Sanz, LG, Cerezuela-Fuentes, P, de la Rosa, CA, Majem, M, Castaño, AG, Berrocal, A, Arroyo, FRG, de la Borbolla, MR, Bellido, L, Martínez, JM, Fernández, LA, Carnicero, AM, Castro, RL, Rodríguez, AB, Lecumberri, MJ, Guzmán, JCV, Balea, BC, Rodríguez, JF, Bautista, JV, Pérez, VN, Mujika, K, Subias, MC, Hernández, B, Algarra, SM, Márquez-Rodas, I. Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801. Clinical & Translational Oncology. 2026; 28(5)DOI:10.1007/s12094-025-04098-3. PMID:41313559. IF:2.500(Q3/6D).
01/05/2026
Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer
Gillessen, S, Gallardo, E, Choudhury, A, Saad, F, Soares, A, Loriot, Y, McDermott, R, Rodriguez-Vida, A, Velho, PI, Nolè, F, Cruz, F, Roumeguere, T, Daugaard, G, Yamamura, R, Bompas, E, Maroto, P, Veiga, FG, Skoneczna, I, da Trindade, KM, Carcano, FM, Lecouvet, F, Coens, C, Poncet, C, Fournier, B, Tombal, B. Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer. ANNALS OF ONCOLOGY. 2026; 37(5)DOI:10.1016/j.annonc.2026.02.009. PMID:41763609. IF:65.400(Q1/1D).
01/05/2026
Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT
Cesaro, S, Garonzi, C, Tridello, G, Verheggen, I, Liu, DH, Flynn, C, Alahmari, A, Kaynar, L, Rabitsch, W, Uygun, V, Chorao, P, Hu, J, Esquirol, A, Piñana, JL, Aljurf, M, Wagner-Drouet, E, Lang, PT, Martin-Sanchez, G, Ratip, S, Facchini, L, Nasilowska-Adamska, B, Styczynski, J, Ram, R, Metafuni, E, Tanase, A, Kalwak, K, Serio, B, Hashem, H, Castagna, L, Vicent, MG, Karakukcu, M, Halahleh, K, Baltadakis, I, Benedetti, E, Mikulska, M, de la Camara, R, Averbuch, D. Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT. BONE MARROW TRANSPLANTATION. 2026; 61(5)DOI:10.1038/s41409-026-02832-1. PMID:41888297. IF:5.200(Q1/1D).
01/05/2026
Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases
Domínguez, JMG, Villar, LM, Arrambide, G, Blanco, Y, Calles, MC, Casanova, B, Castillo-Triviño, T, França, LCF, Eichau, S, Pérez, MAH, Landete, L, Lallana, JM, Oreja-Guevara, C, Prieto, JM, Querol, L, Caminero, AB. Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases. NEUROLOGIA. 2026; 41(4)DOI:10.1016/j.nrl.2025.501928. PMID:. IF:3.100(Q2/4D).
01/05/2026
Low-intervention clinical trials in Spain: Do they progress?
Delgado-Espinoza, CE, Pestana, MJC, Amaro, K, Antonijoan, RM, Pontes, C. Low-intervention clinical trials in Spain: Do they progress?. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; 92(5)DOI:10.1002/bcp.70409. PMID:41406957. IF:3.000(Q2/4D).
01/05/2026
Managing Enterococcus faecium bloodstream infection: a Delphi document on clinical recommendations and research agenda
Rinaldi, M, Bartoletti, M, Cojutti, P, Escolà-Vergé, L, Fernández-Hidalgo, N, Hornuss, D, Gatti, M, Gudiol, C, Gutiérrez-Gutiérrez, B, López-Cortés, LE, Kern, WV, Los-Arcos, I, Muñoz, P, Oliva, A, Papadimitriou-Olivgeris, M, Pai, M, Pea, F, Pericas, JM, Rieg, S, Russo, A, Soriano, A, Thursky, K, Udy, A, Venditti, M, Yahav, D, Mo, Y, Viale, P, Giannella, M. Managing Enterococcus faecium bloodstream infection: a Delphi document on clinical recommendations and research agenda. Eclinicalmedicine. 2026; 95DOI:10.1016/j.eclinm.2026.103925. PMID:42088065. IF:10.000(Q1/1D).
01/05/2026
Impact of COVID-19 on tuberculosis diagnosis in a low-incidence southern European city
Pomar, V, Garrigó, M, Colomé, M, López-Egea, JA, Garcia, E, González, Y, Cermeño, S, Navarro, F, López-Contreras, J. Impact of COVID-19 on tuberculosis diagnosis in a low-incidence southern European city. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2026; 44(5)DOI:10.1016/j.eimc.2026.503173. PMID:. IF:2.500(Q2/5D).
01/05/2026
Effectiveness of automatically-adjusted vs manually-adjusted noninvasive ventilation in obesity hypoventilation syndrome: a randomized clinical trial
Sánchez-Quiroga, MA, Benítez, I, Mokhlesi, B, de Terreros, FJG, Roncero, A, Ruiz-Martínez, C, Bretón, M, Troncoso, MF, Herrero, J, López-Martín, S, López-Padilla, D, González, M, de Teran, TD, Caballero-Eraso, C, Martí, S, Peñacoba, P, Galdeano, M, Muñoz-Méndez, J, Barca, J, Barbe, F, Utrabo, I, Duran, JA, Masa, JF, Chiner, E, De-Dios, C, Lázaro, J, Torres, M, Rodríguez-Rodríguez, P, Esteban, C, Núñez, L, Teran, JR, Asensio-Cruz, MI, Sampol, J, Pallero, M, Hernandez-Voth, A, Díaz-Cambriles, T, Arias, E, Sayas, J. Effectiveness of automatically-adjusted vs manually-adjusted noninvasive ventilation in obesity hypoventilation syndrome: a randomized clinical trial. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2026; 212(5)DOI:10.1093/ajrccm/aamag018. PMID:41738216. IF:19.400(Q1/1D).
01/05/2026
Intumescent cataract and phacomorphic glaucoma: Role of posterior dry vitrectomy in surgical management
Verdu-Reyes, A, Sanchez-Serra, JF, Montero-Garcia, A, Mingorance-Moya, E, Acuña-Salles, M, Avila-Marron, E, Tellez-Vazquez, J, Loscos-Gimenez, I. Intumescent cataract and phacomorphic glaucoma: Role of posterior dry vitrectomy in surgical management. JOURNAL FRANCAIS D OPHTALMOLOGIE. 2026; 49(5)DOI:10.1016/j.jfo.2026.104858. PMID:41955659. IF:1.100(Q3/8D).
01/05/2026
Difference of Admission Neutrophil Gelatinase-Associated Lipocalin Concentration Between Patients Developing and Not Developing Acute Kidney Injury or Need for Acute Dialysis: An Ancillary Individual-Study Data Meta-Analysis (INDICATE-AKI)
Albert, A, Blume, L, Di Somma, S, Hur, M, Bellomo, R, Devarajan, P, Breidthardt, T, Camou, F, Chocron, S, Cruz, D, de Geus, HR, Doi, K, Endre, ZH, Garcia-Alvarez, M, Haase, M, Haase-Fielitz, A, Hjortrup, PB, Karaolanis, G, Kavalci, C, Kim, H, Lange, S, Lauten, P, Lentini, P, Liebetrau, C, Lipcsey, M, Mårtensson, J, Müller, C, Nanas, S, Nickolas, TL, Pickering, JW, Pipili, C, Ronco, C, Rosa-Diez, G, Ralib, AM, Soto, K, Stieger, P, Zapf, A, Braun-Dullaeus, RC, Albert, C. Difference of Admission Neutrophil Gelatinase-Associated Lipocalin Concentration Between Patients Developing and Not Developing Acute Kidney Injury or Need for Acute Dialysis: An Ancillary Individual-Study Data Meta-Analysis (INDICATE-AKI). Kidney Medicine. 2026; 8(5)DOI:10.1016/j.xkme.2026.101280. PMID:41953143. IF:(Q/D).
01/05/2026
A freeze-dried platelet-derived hemostatic agent improves hemostasis in patients with severe thrombocytopenia before and after standard platelet transfusion: Studies ex vivo in the total thrombus-formation analysis system 01
Samanbar, S, Piñeyroa, JA, Moreno-Castaño, AB, Molina, P, Pino, M, Torramade-Moix, S, Martinez-Sanchez, J, Moskowitz, K, Koller, T, Lozano, M, Escolar, G, Diaz-Ricart, M. A freeze-dried platelet-derived hemostatic agent improves hemostasis in patients with severe thrombocytopenia before and after standard platelet transfusion: Studies ex vivo in the total thrombus-formation analysis system 01. TRANSFUSION. 2026; 66(5)DOI:10.1111/trf.70153. PMID:41788007. IF:2.000(Q3/6D).
01/05/2026
Evaluation of grading of recommendations assessment, development, and evaluation approach adherence in clinical practice guidelines: a systematic survey of criteria and their applications
Yan, SY, Guyatt, GH, Ren, XY, Alonso-Coello, P, Dahm, P, Huang, Q, Wang, YB, Jin, YH, Yao, XM. Evaluation of grading of recommendations assessment, development, and evaluation approach adherence in clinical practice guidelines: a systematic survey of criteria and their applications. JOURNAL OF CLINICAL EPIDEMIOLOGY. 2026; 193DOI:10.1016/j.jclinepi.2026.112186. PMID:41722827. IF:5.200(Q1/1D).
01/05/2026
Biological therapy for chronic obstructive pulmonary disease (COPD): Effectiveness and safety
Morales, OMG, Diaz, L, Auladell-Rispau, A, Poloni, D, Torres-López, LA, Cuchi, GU, Rojas-Reyes, MX. Biological therapy for chronic obstructive pulmonary disease (COPD): Effectiveness and safety. RESPIRATORY MEDICINE. 2026; 256DOI:10.1016/j.rmed.2026.108815. PMID:41974360. IF:3.100(Q2/4D).
01/05/2026
Vascular age: a tool to facilitate communication with patients about cardiovascular risk
Brotons, C, Moral, I. Vascular age: a tool to facilitate communication with patients about cardiovascular risk. Clinica E Investigacion En Arteriosclerosis. 2026; 38(3)DOI:10.1016/j.arteri.2026.500936. PMID:41991403. IF:(Q/D).
01/05/2026
Growth Hormone Therapy in 5q35 Duplication Syndrome: Evidence From a Long-Term Follow-Up
Cáceres, A, Carreras, G, Pérez-Jurado, LA. Growth Hormone Therapy in 5q35 Duplication Syndrome: Evidence From a Long-Term Follow-Up. CLINICAL ENDOCRINOLOGY. 2026; 104(5)DOI:10.1111/cen.70089. PMID:41473979. IF:2.400(Q3/7D).
01/05/2026
Transcystic approach in the management of choledocholithiasis: intraoperative complications and technical considerations
Arnau, ABM, Jose, LEGS, Santos, VM, Sánchez-Cabús, S. Transcystic approach in the management of choledocholithiasis: intraoperative complications and technical considerations. CIRUGIA ESPANOLA. 2026; 104(5)DOI:10.1016/j.ciresp.2026.800312. PMID:. IF:1.300(Q3/7D).
01/05/2026
Impact of the 2023 ACR/EULAR antiphospholipid syndrome criteria in 1200 women with prior obstetric antiphospholipid syndrome
Alijotas-Reig, J, Esteve-Valverde, E, Sáez-Comet, L, Anunciación-Llunell, A, Ferrer-Oliveras, R, Lefkou, E, Mekinian, A, Belizna, C, Hoxha, A, Tincani, A, Marozio, L, Espinosa, G, de Carolis, S, Udry, S, Latino, JO, Llurba, E, Chighizola, CB, Gerosa, M, Pengo, V, Lundelin, K, Rovere-Querini, P, Canti, V, Mayer-Pickel, K, Reshetnyak, T, Tabacco, S, Stojanovich, L, Gonçalves, BA, Morales-Perez, S, Miró-Mur, F. Impact of the 2023 ACR/EULAR antiphospholipid syndrome criteria in 1200 women with prior obstetric antiphospholipid syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2026; 321DOI:10.1016/j.ejogrb.2026.115055. PMID:41797084. IF:1.900(Q2/5D).
01/05/2026
Transesophageal echocardiography: A comprehensive assessment of the critically ill patient
Fraile-Gutiérrez, V, Pérez-Torres, D, Martin-Villen, L, Zapata, L, Ochagavia, A. Transesophageal echocardiography: A comprehensive assessment of the critically ill patient. Medicina Intensiva. 2026; 50(5)DOI:10.1016/j.medin.2026.502401. PMID:42020231. IF:3.100(Q2/3D).
01/05/2026
Genotype-phenotype correlations and putative modifier genes in SYNGAP1 Encephalopathy
Aranda, S, Ribeiro-Constante, J, Tristán-Nogueroa, A, Moreno-Ruiz, N, Arenas, C, Calvo, FFM, Ibáñez-Micó, S, Segura, JLP, Ramos-Fernández, JM, Chicanoi, MDM, León, RC, Soto-Insuga, V, González-Alguacil, E, Dávila, CV, Fernández-Jaén, A, Plans, L, Camacho, A, Visa-Reñé, N, Blázquez, MDMT, Paredes-Carmona, F, Marti-Carrera, I, Ginot-Julià, G, Hernández-Fabián, A, Daví, MT, Sànchez, MC, Herraiz, LC, Pitav, PF, González, TB, O'Callaghan, M, Polonia, FFIS, Cazorla, MR, Lucas, MTF, González-Meneses, A, Sala-Coromina, J, Macaya, A, Lasa-Aranzasti, A, Cueto-González, AM, Párraga, FV, Plana, JC, Serrano, M, Alonso, X, Palafoll, MIV, Monteagudo, E, Alonso-Colmenero, I, Capdevila, OS, Casals, F, Cormand, B, García-Cazorla, A, Bayés, A, Mitjans, M. Genotype-phenotype correlations and putative modifier genes in SYNGAP1 Encephalopathy. NEUROBIOLOGY OF DISEASE. 2026; 222DOI:10.1016/j.nbd.2026.107357. PMID:41856439. IF:5.600(Q1/2D).
01/05/2026
[Translated article] N-acetylcysteine: 50 years since the discovery of an antidote that has changed the prognosis of acetaminophen poisoning
Nogué-Xarau, S, Martínez-Sánchez, L, García-Peláez, M, de Gamarra-Martínez, EF, Pi-Sala, N, Gispert-Ametller, A, Salgado-García, E, Aguilar-Salmerón, R. [Translated article] N-acetylcysteine: 50 years since the discovery of an antidote that has changed the prognosis of acetaminophen poisoning. Farmacia Hospitalaria. 2026; 50(3)DOI:10.1016/j.farma.2025.10.015. PMID:41318245. IF:(Q/D).
01/05/2026
N-acetylcysteine: 50 years since the discovery of an antidote that has changed the prognosis of acetaminophen poisoning
Nogué-Xarau, S, Martínez-Sánchez, L, García-Peláez, M, de Gamarra-Martínez, EF, Pi-Sala, N, Gispert-Ametller, A, Salgado-García, E, Aguilar-Salmerón, R. N-acetylcysteine: 50 years since the discovery of an antidote that has changed the prognosis of acetaminophen poisoning. Farmacia Hospitalaria. 2026; 50(3)DOI:10.1016/j.farma.2025.07.005. PMID:40835518. IF:(Q/D).
01/05/2026
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups
Fernández-Mardomingo, A, Subiela, JD, Medina, AA, Krajewski, W, Pichler, R, van Creij, NCH, Lucena, MDDE, de la Parra, I, Ojeda, CM, Coloma, A, Martínez, LC, Durán, PD, González-Padilla, DA, Villacampa, F, Aumatell, J, Scilipoti, P, Longoni, M, Moschini, M, de Angelis, M, Caño-Velasco, J, Contieri, R, Gallioli, A, D'Andrea, D, Acosta, EA, Ajami, T, Grobet-Jeandin, E, Del Giudice, F, Santarelli, V, Slusarczyk, A, Albisinni, S, Soria, F, Mertens, LS, Tully, K, Mari, A, Guerrero-Ramos, F, Alvarez-Maestro, M, Melendres, FA, Buisan, O, Afferi, L, Gajate, P, Guerrero, P, Saiz, A, Pradere, B, Revilla, FJB. Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups. BJU INTERNATIONAL. 2026; 137(5)DOI:10.1111/bju.70207. PMID:41773726. IF:4.400(Q1/2D).
01/05/2026
Reply to Marcio Covas Moschovas, Mischa Dohler, Mohamad Omar Al Kalaa, and Vipul Patel's Letter to the Editor re: Bhaskar K. Somani, Jens Rassweiler, Evangelos Liatsikos, et al. European Association of Urology Policy on Telesurgery. Eur Urol 2025;88:318-24
Somani, BK, Rassweiler, J, Liatsikos, E, Mottrie, A, Knoll, T, Bedke, J, Bianchi, G, Sarica, K, Briganti, A, Brouwers, T, Breda, A. Reply to Marcio Covas Moschovas, Mischa Dohler, Mohamad Omar Al Kalaa, and Vipul Patel's Letter to the Editor re: Bhaskar K. Somani, Jens Rassweiler, Evangelos Liatsikos, et al. European Association of Urology Policy on Telesurgery. Eur Urol 2025;88:318-24. EUROPEAN UROLOGY. 2026; 89(5)DOI:10.1016/j.eururo.2025.11.012. PMID:41344928. IF:25.200(Q1/1D).
01/05/2026
Confirmatory MRI and re-biopsy findings during active surveillance in patients with grade group 2 prostate cancer
Sanguedolce, F, Baboudjian, M, Rlos, AR, Leni, R, Oderda, M, Peyrottes, A, Kesch, C, Al-Nader, M, Uleri, A, Long-Depaquit, T, Dariane, C, Baud, H, Olivier, J, Benard, V, Windisch, O, Valerio, M, Gandaglia, G, Ploussard, G. Confirmatory MRI and re-biopsy findings during active surveillance in patients with grade group 2 prostate cancer. Actas Urologicas Espanolas. 2026; 50(4)DOI:10.1016/j.acuro.2025.501924. PMID:41587602. IF:1.200(Q3/7D).
01/05/2026
Upper Endoscopic kidney-sparing surgery outcomes of high-grade upper tract urothelial cancer
Di Bello, F, Pradere, B, Laukhtina, E, D'Andrea, D, Del Giudice, F, Chung, BI, Krajewski, W, Zattoni, F, Soria, F, Afferi, L, Marcq, G, De Lorenzis, E, Moschini, M, Mari, A, Subiela, JD, Albisinni, S, Izquierdo, P, Dieguez, L, Avesani, G, Territo, A, Basile, G, Palou, J, Breda, A, Gallioli, A. Upper Endoscopic kidney-sparing surgery outcomes of high-grade upper tract urothelial cancer. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; 44(5)DOI:10.1016/j.urolonc.2026.111064. PMID:41876328. IF:2.300(Q2/5D).